Market News AIOpen the app

PMCB stock news · PharmaCyte Biotech, Inc.

Stories about PharmaCyte Biotech, Inc. (PMCB) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for PMCB

Follow PharmaCyte Biotech, Inc. (PMCB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PMCB
Free on the App Store and Google Play, or on the web.
  1. Oct 16, 2026, 5:48 PM ET · Market

    PharmaCyte Biotech, Inc. has switched its accounting firm to Grassi & Co. starting October 14.

    Neutral

    PharmaCyte changed its accounting firm, with no reported dispute or adverse audit opinion. The filing also repeats weaknesses in financial checks, leaving no clear change in the company's outlook.

  2. Sep 25, 2026, 5:22 PM ET · Market

    12 health care companies saw big changes in their stock prices after the market closed on Friday.

    Neutral

    PharmaCyte Biotech shares rose about 5% to $0.47 after hours. The report gives no new business news, so its business outlook remains unchanged.

  3. Sep 25, 2026, 5:19 PM ET · Market

    12 health care companies saw big changes in their stock prices after the market closed on Friday.

    Neutral

    The report says PharmaCyte Biotech shares rose 5.4% after hours, but gives no business update to explain the move. It does not change the company's business outlook.